Recruiting · registry statusAcupuncture alongside Parkinson's medicine
Researchers are testing a specific needle-treatment approach and measuring symptoms and quality of life.
Testing a treatment or activity · Study reference: ChiCTR-INR-17013201
Plain-language introduction written with AI from the registry; not independently checked by a clinician. Read the original details below ↓
This registry record was last updated over six months ago, or its update date is missing. Recruitment may have changed. Confirm with the team before making plans.
Open the official registry record ↗Follow this study
Looking for volunteers
- Start (reported date)
- 2016-10-10
Planned dates can move. A study finishing does not tell us when a paper will be published.
No results summary has been confirmed in the registry records we imported. See connected papers below; we keep checking after recruitment ends.
Changes we have recorded
These are dates we observed a change, not necessarily the dates it happened.
Papers connected to this study
No connected paper has been found yet. The tracker checks the growing library for study identifiers and registry-linked publications.
Who can join?
Ages 40 to 75 · Ask the team who can join
These are starting points, not the full rules. The research team can tell you whether the study is right for your situation.
Read all the rules for taking part
Sex eligibility reported by registry: both
Inclusion criteria: 1. Patients conform to the diagnostic criteria of PD;
2. Aged between 40 and 75 years old;
3. conform to the classification criteria of PD: The stage of revised Hoehn-Yahr Scale between I-III levels;
4. inpatients or outpatients of follow-up;
5. The initial patient, without any treatment of the Parkinson Disease;
6. receive the treatments voluntarily and sign informed consent form.;Inclusion criteria: 1. Patients conform to the diagnostic criteria of PD;
2. Aged between 40 and 75 years old;
3. conform to the classification criteria of PD: The stage of revised Hoehn-Yahr Scale between I-III levels;
4. inpatients or outpatients of follow-up;
5. The initial patient, without any treatment of the Parkinson Disease;
6. receive the treatments voluntarily and sign informed consent form.;Inclusion criteria: 1. Patients conform to the diagnostic criteria of PD;
2. Aged between 40 and 75 years old;
3. conform to the classification criteria of PD: The stage of revised Hoehn-Yahr Scale between I-III levels;
4. inpatients or outpatients of follow-up;
5. The initial patient, without any treatment of the Parkinson Disease;
6. receive the treatments voluntarily and sign informed consent form.;Inclusion criteria: 1. Patients conform to the diagnostic criteria of PD;
2. Aged between 40 and 75 years old;
3. conform to the classification criteria of PD: The stage of revised Hoehn-Yahr Scale between I-III levels;
4. inpatients or outpatients of follow-up;
5. The initial patient, without any treatment of the Parkinson Disease;
6. receive the treatments voluntarily and sign informed consent form.;Inclusion criteria: 1. Patients conform to the diagnostic criteria of PD;
2. Aged between 40 and 75 years old;
3. conform to the classification criteria of PD: The stage of revised Hoehn-Yahr Scale between I-III levels;
4. inpatients or outpatients of follow-up;
5. The initial patient, without any treatment of the Parkinson Disease;
6. receive the treatments voluntarily and sign informed consent form.
Exclusion criteria: 1. secondary Parkinson's disease;
2. Participants with severe primary disease of the cardiovascular, hepatic, renal, or hematopoietic system;
3. patients with a simultaneous psychiatric or other severe disease;
4. Participants who are allergic to the Madopar or Acupuncture.;Exclusion criteria: 1. secondary Parkinson's disease;
2. Participants with severe primary disease of the cardiovascular, hepatic, renal, or hematopoietic system;
3. patients with a simultaneous psychiatric or other severe disease;
4. Participants who are allergic to the Madopar or Acupuncture.;Exclusion criteria: 1. secondary Parkinson's disease;
2. Participants with severe primary disease of the cardiovascular, hepatic, renal, or hematopoietic system;
3. patients with a simultaneous psychiatric or other severe disease;
4. Participants who are allergic to the Madopar or Acupuncture.;Exclusion criteria: 1. secondary Parkinson's disease;
2. Participants with severe primary disease of the cardiovascular, hepatic, renal, or hematopoietic system;
3. patients with a simultaneous psychiatric or other severe disease;
4. Participants who are allergic to the Madopar or Acupuncture.;Exclusion criteria: 1. secondary Parkinson's disease;
2. Participants with severe primary disease of the cardiovascular, hepatic, renal, or hematopoietic system;
3. patients with a simultaneous psychiatric or other severe disease;
4. Participants who are allergic to the Madopar or Acupuncture.
Full study name & original research details
Official study title
Effect of Jin three-needle therapy on quality of life in patients of Parkinson Disease: a multicenter randomized controlled study
Original description
Intervention:
Treatment group:Acupuncture,Madopar;control group:Madopar;
Primary outcome:
UPDRS;Modified Webster;Berg balance scale;PDQ-39;Beck Anxiety Inventory;Beck Depression Inventory;TESS;
Secondary outcome:
HAMD;HAMA;SDS;PDSS;
Conditions reported: Parkinson Disease
Registry records for this study
Records are joined using registration identifiers. Titles alone do not establish that two studies are the same.
- Study type
- Interventional
- Interventions
- Treatment group:Acupuncture,Madopar;control group:Madopar;
- Phases
- New Treatment Measure Clinical Study
- Sponsor
- College of TCM, Southern Medical University
- Start date reported by registry
- 2016-10-10 (reported)
Registry updated: Not reported · Status last verified by the registry submitter: Not reported
Registry records retrieved 2026-10-14 (UTC). Individual records may have older updates. Recruitment and eligibility must be confirmed with the study team.
Contact the research team
Public study contacts supplied to the registry. Ask whether recruitment is still open and what participation involves.
Huang Yong;Huang Yong;Huang Yong;Huang Yong;Huang Yong ;;;; · +86 13719189644;+86 13719189644;+86 13719189644;+86 13719189644;+86 13719189644 · nfhy@fimmu.com;nfhy@fimmu.com;nfhy@fimmu.com;nfhy@fimmu.com;nfhy@fimmu.com
Study locations
Site status can differ from overall study status. “Status not reported” means local availability needs confirmation. Remote participation and travel arrangements must be checked with the team.
Facility not reported
China
Status not reportedThe original descriptions and participation rules come from the registry. Participation is voluntary and does not guarantee benefit.